Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
396.9 USD | -0.21% | +0.02% | -3.08% |
Apr. 25 | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $497 From $515 | MT |
Apr. 23 | Vertex Pharmaceuticals in T1D Licensing Pact With TreeFrog Therapeutics | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.08% | 103B | |
-0.17% | 95.71B | |
+1.11% | 22.02B | |
-17.57% | 20.9B | |
-9.26% | 17.85B | |
-42.83% | 16.21B | |
-15.95% | 15.52B | |
+4.77% | 13.86B | |
+31.70% | 12.04B | |
-25.56% | 8.08B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Goldman Sachs Adjusts Price Target for Vertex Pharmaceuticals to $389 From $368, Maintains Buy Rating